Literature DB >> 18397334

Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.

A Tsakris1, A Ikonomidis, A Poulou, N Spanakis, D Vrizas, M Diomidous, S Pournaras, F Markou.   

Abstract

During a 2-year period (April 2005-March 2007), 31 intensive care unit (ICU) patients in a Greek hospital were infected or colonised with imipenem-resistant isolates of Acinetobacter baumannii. Twelve patients died, with imipenem-resistant A. baumannii infection contributing to the death of seven patients. The 31 representative A. baumannii isolates were multidrug-resistant and clustered in four distinct clones, each of which contained different carbapenemase genes: clone I was predominant and contained bla(VIM-1), bla(OXA-58) and the intrinsic bla(OXA-66) gene; clone II contained bla(VIM-4), bla(OXA-58) and the intrinsic bla(OXA-69) gene; clone III contained bla(OXA-58) and the intrinsic bla(OXA-69) gene; and clone IV contained only the intrinsic bla(OXA-66) gene. ISAba1 was not associated with the intrinsic bla(OXA-51-like) alleles, whereas ISAba3 was found upstream and downstream of bla(OXA-58) in isolates of clone I, and upstream of bla(OXA-58) in isolates of clone III, but was not detected in isolates of clone II. PCR, curing and hybridisation experiments indicated that the bla(VIM) alleles were chromosomally located, whereas the bla(OXA-58) alleles were plasmid-located. This study provides the first description of the clonal spread of multidrug-resistant A. baumannii isolates carrying bla(VIM-1) and bla(VIM-4) metallo-beta-lactamase genes, and revealed that distinct carbapenem-resistant A. baumannii clusters bearing different carbapenemase genes may emerge and cause severe infections, even in a well-defined regional hospital setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18397334     DOI: 10.1111/j.1469-0691.2008.01996.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  20 in total

1.  Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii.

Authors:  Mark D Adams; E Ricky Chan; Neil D Molyneaux; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

2.  Use of the accessory genome for characterization and typing of Acinetobacter baumannii.

Authors:  Jane F Turton; Buket Baddal; Claire Perry
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

3.  Overexpression of the naturally occurring blaOXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9.

Authors:  Samy Figueiredo; Laurent Poirel; Anna Papa; Vassiliki Koulourida; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

Review 4.  Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade.

Authors:  G Meletis; D Chatzidimitriou; N Malisiovas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-18       Impact factor: 3.267

5.  Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital.

Authors:  G Samonis; I P Korbila; S Maraki; I Michailidou; K Z Vardakas; D Kofteridis; D Dimopoulou; V K Gkogkozotou; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-15       Impact factor: 3.267

6.  Trends in the molecular epidemiology of carbapenem resistant acinetobacter baumannii in a tertiary Greek hospital.

Authors:  V Koulourida; E Martziou; K Tsergouli; A Papa
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

7.  Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone.

Authors:  Maria Giannouli; Susanna Cuccurullo; Valeria Crivaro; Anna Di Popolo; Mariano Bernardo; Federica Tomasone; Gerardino Amato; Sylvain Brisse; Maria Triassi; Riccardo Utili; Raffaele Zarrilli
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

8.  Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.

Authors:  Olga Tsiatsiou; Εlias Iosifidis; Aspasia Katragkou; Vasiliki Dimou; Kosmas Sarafidis; Theodoros Karampatakis; Charalampos Antachopoulos; Anagnostina Orfanou; Athanasios Tsakris; Vasiliki Drossou-Agakidou; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2014-07-02       Impact factor: 3.183

9.  Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.

Authors:  Federico Perez; Andrea Endimiani; Amy J Ray; Brooke K Decker; Christopher J Wallace; Kristine M Hujer; David J Ecker; Mark D Adams; Philip Toltzis; Michael J Dul; Anne Windau; Saralee Bajaksouzian; Michael R Jacobs; Robert A Salata; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2010-05-31       Impact factor: 5.790

Review 10.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.